Miko Yu

945 total citations · 1 hit paper
43 papers, 557 citations indexed

About

Miko Yu is a scholar working on Public Health, Environmental and Occupational Health, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miko Yu has authored 43 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 29 papers in Transplantation and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miko Yu's work include Renal Transplantation Outcomes and Treatments (29 papers), Organ Donation and Transplantation (27 papers) and Renal and Vascular Pathologies (14 papers). Miko Yu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (29 papers), Organ Donation and Transplantation (27 papers) and Renal and Vascular Pathologies (14 papers). Miko Yu collaborates with scholars based in United States and United Kingdom. Miko Yu's co-authors include Jim C. Hu, Ashwin Ramaswamy, Patrick J. Culligan, Siri Drangsholt, Peter N. Schlegel, Sumit Mohan, S. Ali Husain, Kristen L. King, Jesse D. Schold and Joel T. Adler and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Journal of the American Society of Nephrology.

In The Last Decade

Miko Yu

34 papers receiving 551 citations

Hit Papers

Patient Satisfaction With Telemedicine During the COVID-1... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miko Yu United States 9 350 184 149 131 115 43 557
Bernice Coleman United States 15 95 0.3× 65 0.4× 36 0.2× 65 0.5× 72 0.6× 49 677
Jolanta Karpinski Canada 12 346 1.0× 71 0.4× 15 0.1× 249 1.9× 123 1.1× 30 635
Sandra R. DiBrito United States 15 167 0.5× 90 0.5× 81 0.5× 107 0.8× 120 1.0× 56 674
Julius Wilder United States 15 146 0.4× 118 0.6× 73 0.5× 76 0.6× 31 0.3× 43 728
Matthew P. Landman United States 14 116 0.3× 64 0.3× 60 0.4× 15 0.1× 154 1.3× 50 637
Janine Schirmer Brazil 13 393 1.1× 139 0.8× 46 0.3× 45 0.3× 20 0.2× 113 665
P Yudkin United Kingdom 18 170 0.5× 112 0.6× 70 0.5× 42 0.3× 88 0.8× 29 777
Yang‐Jen Chiang Taiwan 14 214 0.6× 66 0.4× 76 0.5× 165 1.3× 122 1.1× 83 713
David Forner Canada 15 71 0.2× 81 0.4× 170 1.1× 14 0.1× 96 0.8× 57 569
Andrea Burón Spain 18 61 0.2× 142 0.8× 465 3.1× 25 0.2× 216 1.9× 40 885

Countries citing papers authored by Miko Yu

Since Specialization
Citations

This map shows the geographic impact of Miko Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miko Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miko Yu more than expected).

Fields of papers citing papers by Miko Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miko Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miko Yu. The network helps show where Miko Yu may publish in the future.

Co-authorship network of co-authors of Miko Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Miko Yu. A scholar is included among the top collaborators of Miko Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miko Yu. Miko Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Miko, et al.. (2025). Financial Toxicity in ESKD. Kidney360. 6(11). 1928–1938.
2.
Mohan, Sumit, Miko Yu, Joel T. Adler, et al.. (2025). Out-of-Sequence Placement of Deceased Donor Kidneys Is Exacerbating Inequities in the United States. Clinical Journal of the American Society of Nephrology. 21(1). 130–138.
3.
Schold, Jesse D., Susana Arrigain, S. Ali Husain, et al.. (2025). Variation of eGFR Wait Time Modifications for Black Kidney Transplant Candidates in the United States. Journal of the American Society of Nephrology. 36(10). 2019–2029. 1 indexed citations
4.
Yu, Miko, Joel T. Adler, David C. Cron, et al.. (2025). Underrecognition of deceased donor kidney out-of-sequence allocation due to increasing use of free-text coding. American Journal of Transplantation. 25(8). 1715–1722. 3 indexed citations
5.
Husain, S. Ali, Miko Yu, Sandra Amaral, et al.. (2025). Consent to Receive Offers for Kidneys From Donors With Hepatitis C Among Pediatric Kidney Transplant Candidates in the United States. Pediatric Transplantation. 29(7). e70167–e70167.
6.
Schold, Jesse D., Jordan Hoffman, Sumit Mohan, et al.. (2025). Association of the initial implementation of continuous distribution allocation policy with outcomes for lung transplant candidates by blood type. American Journal of Transplantation. 25(8). 1756–1764.
8.
Mohan, Sumit, Miko Yu, Joel T. Adler, et al.. (2025). Outcomes for Patients With a Deceased Donor Kidney Offer in the New Allocation System. Kidney International Reports. 10(4). 1111–1121. 1 indexed citations
9.
Yu, Miko, et al.. (2025). Acceptance of High Kidney Donor Profile Index Kidneys Among Consented Candidates. Kidney International Reports. 10(9). 3094–3101.
10.
Yu, Miko, Sandra Amaral, Joel T. Adler, et al.. (2024). Disparities in Access to Timely Waitlisting Among Pediatric Kidney Transplant Candidates. PEDIATRICS. 154(3). 3 indexed citations
12.
Lange, Nicholas W., Kristen L. King, S. Ali Husain, et al.. (2024). Obesity is associated with a higher incidence of rejection in patients on belatacept: A pooled analysis from the BENEFIT/BENEFIT-EXT clinical trials. American Journal of Transplantation. 24(6). 1027–1034. 1 indexed citations
13.
Ratner, Lloyd E., et al.. (2024). Kidney Transplant in Children: Strategic Timing During Summer School Breaks. Kidney Medicine. 6(8). 100864–100864. 1 indexed citations
14.
Cron, David C., Layla Parast, S. Ali Husain, et al.. (2024). Associations Among Circle-Based Kidney Allocation, Center Waiting Time, and Likelihood of Deceased-Donor Kidney Transplantation. American Journal of Kidney Diseases. 85(2). 187–195. 4 indexed citations
15.
Yu, Miko, et al.. (2024). Incomplete reporting of clinically significant acute rejection episodes in the national kidney transplant registry. American Journal of Transplantation. 24(10). 1828–1836. 3 indexed citations
16.
King, Kristen L., S. Ali Husain, Miko Yu, et al.. (2023). Characterization of Transplant Center Decisions to Allocate Kidneys to Candidates With Lower Waiting List Priority. JAMA Network Open. 6(6). e2316936–e2316936. 21 indexed citations
17.
Yu, Miko, et al.. (2023). Effects of Delayed Graft Function on Transplant Outcomes: A Meta-analysis. Transplantation Direct. 9(2). e1433–e1433. 27 indexed citations
18.
King, Kristen L., Miko Yu, S. Ali Husain, et al.. (2022). Contribution of Estimates of Glomerular Filtration to the Extensive Disparities in Preemptive Listing for Kidney Transplant. Kidney International Reports. 8(3). 442–454. 8 indexed citations
19.
Basourakos, Spyridon P., Miko Yu, Jessica S. Ancker, et al.. (2021). Perceptions of partial gland ablation for prostate cancer among men on active surveillance: a qualitative study. SHILAP Revista de lepidopterología. 3(1). e000068–e000068. 1 indexed citations
20.
Awamlh, Bashir Al Hussein Al, et al.. (2019). IDEAL Stage 2a experience with in-office, transperineal MRI/ultrasound software fusion targeted prostate biopsy. SHILAP Revista de lepidopterología. 1(1). e000025–e000025. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026